Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.80
-0.83 (-6.09%)
Jan 23, 2026, 4:00 PM EST - Market closed
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $250.24 million as of January 23, 2026.
Market Cap
250.24M
Enterprise Value
252.95M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.80
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $250.24M, a decrease of -18.96%. That is a compound annual growth rate of -29.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 250.24M | 7.93% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 286.71M |
| Atea Pharmaceuticals | 285.16M |
| Cabaletta Bio | 283.02M |
| Immix Biopharma | 276.65M |
| Shattuck Labs | 275.90M |
| Palisade Bio | 275.66M |
| Silence Therapeutics | 274.90M |
| Fennec Pharmaceuticals | 266.40M |